NorthCrest Asset Manangement’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1M | Buy |
132,664
+199
| +0.2% | +$37.7K | 0.67% | 38 |
|
|
2025
Q1 | $27.8M | Buy |
132,465
+836
| +0.6% | +$175K | 0.84% | 29 |
|
|
2024
Q4 | $23.4M | Buy |
131,629
+574
| +0.4% | +$102K | 0.7% | 37 |
|
|
2024
Q3 | $25.9M | Buy |
131,055
+2,127
| +2% | +$420K | 0.78% | 32 |
|
|
2024
Q2 | $22.1M | Buy |
128,928
+3,681
| +3% | +$631K | 0.73% | 34 |
|
|
2024
Q1 | $22.8M | Sell |
125,247
-116
| -0.1% | -$21.1K | 0.78% | 36 |
|
|
2023
Q4 | $19.4M | Sell |
125,363
-1,167
| -0.9% | -$181K | 0.73% | 36 |
|
|
2023
Q3 | $18.9M | Buy |
126,530
+125,730
| +15,716% | +$18.7M | 0.77% | 35 |
|
|
2023
Q2 | $7.48K | Buy |
+800
| New | +$7.48K | ﹤0.01% | 496 |
|
|
2023
Q1 | – | Sell |
-92,036
| Closed | -$14.9M | – | 484 |
|
|
2022
Q4 | $14.9M | Sell |
92,036
-3,474
| -4% | -$561K | 0.85% | 41 |
|
|
2022
Q3 | $12.8M | Buy |
95,510
+718
| +0.8% | +$96.4K | 0.69% | 51 |
|
|
2022
Q2 | $14.5M | Buy |
94,792
+383
| +0.4% | +$58.7K | 0.74% | 47 |
|
|
2022
Q1 | $15.3M | Buy |
94,409
+2,503
| +3% | +$406K | 0.73% | 52 |
|
|
2021
Q4 | $12.4M | Buy |
+91,906
| New | +$12.4M | 0.68% | 46 |
|